Pfizer Inc. logo

Pfizer Inc.

PFE | NYSE
Chart Builder DCF Calculator
$27.74
+$0.08 (+0.29%)
At close: Sep 21, 2026, 4:02 PM ET
$27.75
+$0.01 (+0.04%)
After-hours: Sep 21, 2026, 7:52 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Revenue
62.58B 63.63B 59.55B 100.33B 81.29B 41.65B
Cost of Revenue
18.57B 21.78B 29.21B 38.24B 34.41B 11.77B
Gross Profit
44.01B 41.85B 30.34B 62.09B 46.88B 29.88B
Operating Income
15.44B 16.48B 5.29B 37.55B 20.79B 9.09B
Interest Income
603M 545M 1.62B 251M 36M 73M
Pretax Income
7.52B 8.02B 1.06B 34.73B 24.31B 7.04B
Net Income
7.77B 8.02B 2.13B 31.37B 22.15B 9.16B
Selling & General & Admin
13.35B 14.73B 14.47B 13.12B 12.25B 11.4B
Research & Development
11.98B 10.74B 10.58B 11.43B 13.83B 9.4B
Other Expenses
3.26B -105M n/a n/a n/a n/a
Operating Expenses
28.58B 25.36B 25.05B 24.54B 26.08B 20.8B
Interest Expense
2.67B 3.09B 2.21B 1.24B 1.29B 1.45B
Selling & Marketing Expenses
n/a 3.3B n/a n/a n/a n/a
Cost & Expenses
47.14B 47.14B 54.26B 62.78B 60.5B 32.57B
Income Tax Expense
-266M -28M -1.11B 3.33B 1.85B 370M
Shares Outstanding (Basic)
5.68B 5.66B 5.64B 5.61B 5.6B 5.56B
Shares Outstanding (Diluted)
5.69B 5.7B 5.71B 5.73B 5.71B 5.63B
EPS (Basic)
1.36 1.42 0.38 5.59 3.95 1.65
EPS (Diluted)
1.36 1.41 0.37 5.47 3.88 1.63
EBITDA
15.1B 18.13B 9.56B 41.03B 30.79B 13.17B
EBIT
10.19B 11.11B 3.27B 35.97B 25.6B 8.49B
Depreciation & Amortization
4.91B 7.01B 6.29B 5.06B 5.19B 4.68B

© 2026 bestshares.com. All rights reserved.